Matches in Nanopublications for { ?s ?p "[RASSF1A promoter hypermethylation was detected in 100% of SCLC, in 63% of NSCLC, in 64% of breast cancer lines, in 30% of primary NSCLCs, and in 49% of primary breast tumors but in none of the nonmalignant lung tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP296583.RARKHogZv3hkmRDG4v9Lb8HwjMhFujALUe7ElC_PjbzRs130_assertion description "[RASSF1A promoter hypermethylation was detected in 100% of SCLC, in 63% of NSCLC, in 64% of breast cancer lines, in 30% of primary NSCLCs, and in 49% of primary breast tumors but in none of the nonmalignant lung tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296583.RARKHogZv3hkmRDG4v9Lb8HwjMhFujALUe7ElC_PjbzRs130_provenance.
- NP696905.RAyoEzz_tz-t8SH2ktNOC9FZCyuerjodXQiuSeAFZXb0Q130_assertion description "[RASSF1A promoter hypermethylation was detected in 100% of SCLC, in 63% of NSCLC, in 64% of breast cancer lines, in 30% of primary NSCLCs, and in 49% of primary breast tumors but in none of the nonmalignant lung tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP696905.RAyoEzz_tz-t8SH2ktNOC9FZCyuerjodXQiuSeAFZXb0Q130_provenance.
- assertion description "[RASSF1A promoter hypermethylation was detected in 100% of SCLC, in 63% of NSCLC, in 64% of breast cancer lines, in 30% of primary NSCLCs, and in 49% of primary breast tumors but in none of the nonmalignant lung tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[RASSF1A promoter hypermethylation was detected in 100% of SCLC, in 63% of NSCLC, in 64% of breast cancer lines, in 30% of primary NSCLCs, and in 49% of primary breast tumors but in none of the nonmalignant lung tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_assertion description "[RASSF1A promoter hypermethylation was detected in 100% of SCLC, in 63% of NSCLC, in 64% of breast cancer lines, in 30% of primary NSCLCs, and in 49% of primary breast tumors but in none of the nonmalignant lung tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_provenance.
- NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_assertion description "[RASSF1A promoter hypermethylation was detected in 100% of SCLC, in 63% of NSCLC, in 64% of breast cancer lines, in 30% of primary NSCLCs, and in 49% of primary breast tumors but in none of the nonmalignant lung tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_provenance.